In 2013, the Positivrat Schweiz, the Patient Advocates for Cancer Research and Treatment (PACRT), the Swiss Clinical Trial Organisation (SCTO) and the University Hospital Basel (USB) created an informal network of stakeholders in Switzerland interested in medicines research and development and patient involvement. Shortly thereafter, the team began to collaborate closely with Swissmedic, the Swiss Agency for Therapeutic Products.
In 2014, representatives from other patient organisations and the pharmaceutical industry joined the network and together several public events were organised to raise awareness for EUPATI in Switzerland (2014 in Bern, 2015 in Lausanne and 2016 in Bern).
With the aim to support patient involvement in medicines research and development in Switzerland, we decided to formalise the Swiss network to a legal entity. On October 4, 2016 the National Platform became the legal entity of an association under Swiss law – EUPATI CH.
For more information please visit our association section or contact us ([email protected]).
